Mebendazole Inexplicably Reducing the Breast Cancer Cells Viability Preclinically by Incitement Effects with Methotrexate
Journal Title: RADS Journal of Pharmacy and Pharmaceutical Sciences - Year 2018, Vol 6, Issue 2
Abstract
Objective: To perform preclinical (in vitro) interventional trial of mebendazole. Methods: This study carried out in Basic Medical Science Institute, JMPC in alliance with PCMD. The total study duration from March 2016 to February 2017. For assessment of cytotoxic incitement effects of mebendazole with methotrexate we used six different dilutions of mebendazole (1.5µM - 100µM) both as alone and in combination with methotrexate (0.5µM-100µM). Cytotoxicity was assessed by MTT and trypan blue dye exclusion cytotoxicity assays. We used primarily two breast cancerous cell lines MCF-7 (representative of invasive ductal carcinoma) and MDA-MB-231 (representative of adenocarcinoma). Results: Mebendazole more effectively reducing the % viability of studied cancerous cell lines as combination therapy with methotrexate. The average percentage decrease of % viability of MCF-7 and MDA-MB-231 were -81.3097 and -66.8711 respectively. This combination showed selectivity towards cancerous cell lines as indicated by non-significant (p=0.183) effects on normal breast epithelial cell line (MCF-10). Conclusion: This study demonstrated that combination therapy of mebendazole with standard chemotherapeutic agent methotrexate unveil incitement effects.
Authors and Affiliations
Fatima Rizvi
Keywords
Related Articles
- EP ID EP604596
- DOI -
- Views 173
- Downloads 0
Comprehensive Study and Impact of Microbial Growth on Treated and Un-Treated Herbal Extracts
Purpose of Study: The purpose of the study is to determine the presence of microorganisms in the herbal thick extracts which are being used in different phyto pharmaceutical industries for manufacturing of different dosa...
Formulation and In-Vitro Evaluation of Polymers Blend Based Diclofenac Sodium Microparticles for Sustained Release Drug Delivery
Purpose: The purpose of research was to formulate polymeric blend based Diclofenac sodium microparticles for sustained release drug delivery. Method: The diclofenac sodium microparticles were formulated by emulsificatio...
A Novel RP-HPLC Method for Simultaneous Determination of Moxifloxacin and Atorvastatin
Objectives:A RP-HPLC method was validated which is simple, rapid and accurate for simultaneous determination and quantification of Moxifloxacin in presence of Atorvastatin. Methodology:Chromatographic separation was ach...
Formulation development and assessment of Naproxen sodium tablet (Anti rheumatic agent)
Background: Naproxen sodium has been extensively used as an anti-pyretic, anti-inflammatory and analgesic agent. Naproxen sodium tablet contains non-active ingredients like maize starch, microcrystalline cellulose, cross...
Linezolid Study on Isolates of Staphylococcus aureus and Escherichia coli Through Disc Diffusion Method
Objective: The objective of this study was to evaluate the effectiveness of Linezolid on Staphylococcus aureus and Escherichia coli through disc diffusion method. Methods: Discs of Linezolid were used for the evaluation...